Research activity

Here is a list of all the research activity pages:

Generic List

Cognitive development research - School of Psychology

Description
We are interested in how thinking and reasoning abilities develop, and we run experimental studies with young children. Current projects include children's theory of mind from 3-7 years; children's understanding of the representational nature of words and pictures; the developmental relationship between reasoning and executive functions; children's understanding of possibility and uncertainty, including handling ambiguity and counterfactual thinking. Members of the research team also have interests in adult cognition and neuropsychology.

Cognitive neuroimaging research - School of Psychology

Description
The Cognitive Neuroimaging group uses multimodal neuroimaging techniques (structural and functional MRI, EEG, MEG) to analyse the neural architecture (cortical areas and their connectivity) mediating visual cognition in complex environments.

Cold Atoms - Physics and Astronomy research

Description
The Ultra Cold Atoms Research Group was set up during 2008 as a new group within the School of Physics and Astronomy. The group is part of the Midlands Ultra Cold Atoms Research Centre (MUARC) and of the quantum hub for sensors and metrology

Compare

Description
CompARE: Phase III randomised controlled trial Comparing Alternative Regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer

Contact - Centre in Computational Neuroscience and Cognitive Robotics

Description
CNCR, c/o School of Psychology University of Birmingham Edgbaston Birmingham B15 2TT UKTel: +44 (0)121 414 4932 Fax: +44 (0)121 414 489

Contact the ASTRAL team

Description
ASTRAL is a multicentre, randomized, unblinded clinical trial, comparing revascularisation in addition to medical therapy versus medical therapy alone in patients with atherosclerotic renovascular disease (ARVD). The aim of ASTRAL is to assess whether renal arterial revascularisation with balloon angioplasty and/or endovascular stenting can safely prevent progressive renal failure among patients with ARVD. ASTRAL closed to recruitment in October 2007 having recruited 806 patients, and is now in long term follow up until 2017. The trial is managed by the BCTU at the University of Birmingham.
Displaying 51 to 60 of 117
Previous 4 5 6 7 8 Next